Home  » Topic

Wockhardt News


Stocks of Wockhardt Declines By 8% Post-Bleak Financial Results
Wockhardt - the global pharmaceutical and biotechnology organization's stock has dipped by 8 percent after the company announced its financial results. The company reported its fourth quarter and fiscal 2018 results on Friday, May 4, 2018. Based on the financial ...
Bluechip Pharma Stocks At 52-Week Lows; Should You Buy?
The miseries for pharma stocks just does not seem to end. We now have several stocks hitting 52-week lows with Lupin Ltd and Aurobindo Pharma, joining the likes of Dr Reddy's at 52-week lows. Other stocks like Sun Pharma and Divis ...
High Risk Stocks That Can Generate High Returns
Before we begin recommending the stocks, we wish to state that the stocks that are being recommended are high risk ones, which have the potential to generate returns, should there be a better financial performance. These stocks have largely been hammered ...
Sensex Open Higher As Global Markets Bounce Back
Benchmark indices opened the day higher as global markets staged a good comeback, following the strong US jobs data. The Sensex was trading with gains of 121 points, while the Nifty rallied 38 points in early trade. Leading the set of ...
Why Indian Pharma Shares Have Become Risky Bets?
From being the safest bets until the last few months, pharma shares in the last few weeks have become the riskiest bets in the markets. The one and the only one reason is warning letters from the US FDA. Take the ...
Why Pharma Shares Are Not A Great Buy?
If there are two sectors that are highly over priced, it is the pharma and FMCG sector. The rationale and logic for such high valuations in the pharma sector is difficult to explain. In fact, its simply because investors, particularly ...
Get Instant News Updates
Enable
x
Notification Settings X
Time Settings
Done
Clear Notification X
Do you want to clear all the notifications from your inbox?
Settings X